Global Antihistamines Market Is Expected To Grow At 8.7% CAGR During The Forecast Period 2018 – 2026

According to the latest report published by Credence Research, Inc. “Antihistamines Market – Growth, Future Prospects and Competitive Analysis, 2018-2026,” the global antihistamines market will grow at a CAGR of 8.7% from 2018 to 2026.

Browse the full report Antihistamines Market – Growth, Future Prospects and Competitive Analysis, 2018-2026 report at

Antihistamines Market

Market Insights

The global antihistamines market is expected to grow at a CAGR of 8.7% during the forecast period from 2018 to 2026. Histamine is a key intermediary of instant hypersensitivity reactions acting locally and assisting vasodilation, smooth muscle contraction, high vascular permeability, inflammation, and edema. Antihistamines are representative of a class of drugs that inhibit the histamine type 1 (H1) receptors. H1 receptor is present on smooth muscle of bronchi, gastrointestinal tract, uterus, and large blood vessels. The major application of antihistamines has been observed in treatment of symptoms such as allergic conditions including itching, runny nose, nasal stuffiness, urticaria, teary eyes, dizziness, cough, and nausea. A few common side effects observed due to antihistamines treatment are sedation, impaired motor function, dry mouth & throat, dizziness, blurred vision, constipation and urinary retention. However, since a few decades modern drug development technologies have helped to reduce aforementioned side effects of antihistamines.

Key Trends:

Key players in the market include Bayer AG, Almirall S.A., Johnson & Johnson, AstraZeneca plc, Novartis AG, Pfizer, Inc., Sanofi SA, Boehringer Ingelheim GmbH, Merck & Co., Inc., Akorn, Inc., Teva Pharmaceutical Industries Ltd., and others.

Industry Outlook

The global antihistamines market will grow at a CAGR of 8.7% during the forecast period from 2018 to 2026. Antihistamines exemplify a class of drugs that block the histamine type-1 (H1) receptors. H1-receptors are extensively scattered and predominantly found on smooth muscle of the gastrointestinal tract, bronchi, uterus, and large blood vessels. The key applications of antihistamines are allergic rhinitis, conjunctivitis, urticaria, atopic dermatitis, anaphylaxis, and others. In year 2016 according to European Academy of Allergy and Clinical Immunology (EAACI), around 150 million or more Europeans suffer from chronic allergic conditions and further anticipated that by 2025 half of the total population of Europe will suffer with chronic allergic diseases. Thus, rising global prevalence of allergies expected to increase the demand for antihistamines in the near future.

Full Report Visit:

Market Synopsis

Antihistamines Market

Second-generation antihistamines expected to retain its market dominance during the forecast period

Second-generation antihistamines such as acrivastine, cetirizine, desloratadine, fexofenadine, levocetirizine, and loratadine are preferred as first-line of treatment in diseases such as allergic rhinitis, urticaria, and atopic dermatitis. The key factors assisting the growth of second-generation antihistamines are rising prevalence of allergies, increasing awareness related to early diagnosis & treatment of allergies, and overall development in the treatment technology. However, the main reason for prescribing second-generation antihistamines is there are very few second-generation antihistamines that cross blood-brain barrier and have sedating effect. Cetirizine causes drowsiness that may lead to accidents with people driving car or handling heavy machinery. Thus, levocetirizine is now preferred over cetirizine due to its non-sedating effect. Second-generation antihistamines possess a longer duration of action and plasma half-life compared to first generation drugs, which makes it easy to decrease the number of daily intakes.

Antihistamines Market

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions

Chapter 2. Executive Summary
2.1. Global Antihistamines Market Portraiture
2.2. Global Antihistamines Market, by Antihistamines Type, 2017 (US$ Mn)
2.3. Global Antihistamines Market, by Application, 2017 (US$ Mn)
2.4. Global Antihistamines Market, by Geography, 2017 (US$ Mn)

Chapter 3. Antihistamines: Market Dynamics and Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Antihistamines Market, by Key Players, 2017 …

Chapter 7. Profiles
7.1. Bayer AG
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Almirall S.A.
7.3. Johnson & Johnson
7.4. AstraZeneca plc
7.5. Novartis AG …

For Sample Request:

Inquire Before Buying this Reports:

Share this post